{"id":16433,"date":"2025-12-03T11:39:32","date_gmt":"2025-12-03T10:39:32","guid":{"rendered":"https:\/\/innoprot.com\/?p=16433"},"modified":"2026-01-19T13:29:53","modified_gmt":"2026-01-19T12:29:53","slug":"article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study","status":"publish","type":"post","link":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/","title":{"rendered":"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study"},"content":{"rendered":"<p>Allergic conjunctivitis (AC) is the most common form of allergic eye disease and an increasingly prevalent condition. Topical eye drop treatments are the usual approach for managing AC, although their impact on the ocular surface is not frequently investigated. The aim of this study was to perform a comparative physicochemical characterization, and in vitro biological evaluations in primary conjunctival and corneal epithelial cells of the new multidose preservative-free bilastine 0.6% and main commercially available eye drops. Bilastine and single-dose ketotifen and azelastine showed high survival rates attributable to the absence of preservative in its formulation, not inducing caspase-3\/7-mediated apoptosis after 24 h. Our findings support the use of the new bilastine 0.6% for treating patients with AC to preserve and maintain the integrity of the ocular surface.<\/p>\n<p>Scientific Reports. 2024 Apr 26<\/p>\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38671063\/\">More information<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Allergic conjunctivitis (AC) is the most common form of allergic eye disease and an increasingly prevalent condition. Topical eye drop treatments are the usual approach for managing AC, although their impact on the ocular surface is not frequently investigated. The aim of this study was to perform a comparative physicochemical characterization, and in vitro biological [&hellip;]<\/p>\n","protected":false},"author":9192194,"featured_media":16434,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1005],"tags":[1000],"class_list":["post-16433","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-scientific-publications","tag-allergic-conjunctivitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study &#8212; Innoprot<\/title>\n<meta name=\"description\" content=\"New preservative-free bilastine 0.6% effective in maintaining ocular surface integrity for allergic conjunctivitis treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study &#8212; Innoprot\" \/>\n<meta property=\"og:description\" content=\"New preservative-free bilastine 0.6% effective in maintaining ocular surface integrity for allergic conjunctivitis treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Innoprot\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T10:39:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T12:29:53+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/innoprot.com\/wp-content\/uploads\/2025\/12\/Scientific-reports.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Innoprot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Innoprot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/\"},\"author\":{\"name\":\"Innoprot\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#\\\/schema\\\/person\\\/62d601aa196bf9199550a161636ed83f\"},\"headline\":\"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study\",\"datePublished\":\"2025-12-03T10:39:32+00:00\",\"dateModified\":\"2026-01-19T12:29:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/\"},\"wordCount\":151,\"publisher\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innoprot.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Scientific-reports.jpg\",\"keywords\":[\"Allergic conjunctivitis\"],\"articleSection\":[\"Scientific publications\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/\",\"url\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/\",\"name\":\"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study &#8212; Innoprot\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innoprot.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Scientific-reports.jpg\",\"datePublished\":\"2025-12-03T10:39:32+00:00\",\"dateModified\":\"2026-01-19T12:29:53+00:00\",\"description\":\"New preservative-free bilastine 0.6% effective in maintaining ocular surface integrity for allergic conjunctivitis treatment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innoprot.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Scientific-reports.jpg\",\"contentUrl\":\"https:\\\/\\\/innoprot.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Scientific-reports.jpg\",\"width\":500,\"height\":500,\"caption\":\"The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/innoprot.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/innoprot.com\\\/es\\\/\",\"name\":\"Innoprot\",\"description\":\"Speeding up drug discovery\",\"publisher\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#organization\"},\"alternateName\":\"Innoprot\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innoprot.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#organization\",\"name\":\"Innoprot\",\"alternateName\":\"Innoprot\",\"url\":\"https:\\\/\\\/innoprot.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/innoprot.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo-blanco-innoprot-1.png\",\"contentUrl\":\"http:\\\/\\\/innoprot.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo-blanco-innoprot-1.png\",\"width\":201,\"height\":54,\"caption\":\"Innoprot\"},\"image\":{\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/innoprot.com\\\/es\\\/#\\\/schema\\\/person\\\/62d601aa196bf9199550a161636ed83f\",\"name\":\"Innoprot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/caa3a92dcc44f0c616f60f902c05e27a6a7a2d94157c9a2329dc725e1d3a5966?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/caa3a92dcc44f0c616f60f902c05e27a6a7a2d94157c9a2329dc725e1d3a5966?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/caa3a92dcc44f0c616f60f902c05e27a6a7a2d94157c9a2329dc725e1d3a5966?s=96&d=mm&r=g\",\"caption\":\"Innoprot\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study &#8212; Innoprot","description":"New preservative-free bilastine 0.6% effective in maintaining ocular surface integrity for allergic conjunctivitis treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/","og_locale":"es_ES","og_type":"article","og_title":"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study &#8212; Innoprot","og_description":"New preservative-free bilastine 0.6% effective in maintaining ocular surface integrity for allergic conjunctivitis treatment.","og_url":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/","og_site_name":"Innoprot","article_published_time":"2025-12-03T10:39:32+00:00","article_modified_time":"2026-01-19T12:29:53+00:00","og_image":[{"width":500,"height":500,"url":"http:\/\/innoprot.com\/wp-content\/uploads\/2025\/12\/Scientific-reports.jpg","type":"image\/jpeg"}],"author":"Innoprot","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Innoprot","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#article","isPartOf":{"@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/"},"author":{"name":"Innoprot","@id":"https:\/\/innoprot.com\/es\/#\/schema\/person\/62d601aa196bf9199550a161636ed83f"},"headline":"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study","datePublished":"2025-12-03T10:39:32+00:00","dateModified":"2026-01-19T12:29:53+00:00","mainEntityOfPage":{"@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/"},"wordCount":151,"publisher":{"@id":"https:\/\/innoprot.com\/es\/#organization"},"image":{"@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#primaryimage"},"thumbnailUrl":"https:\/\/innoprot.com\/wp-content\/uploads\/2025\/12\/Scientific-reports.jpg","keywords":["Allergic conjunctivitis"],"articleSection":["Scientific publications"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/","url":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/","name":"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study &#8212; Innoprot","isPartOf":{"@id":"https:\/\/innoprot.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#primaryimage"},"image":{"@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#primaryimage"},"thumbnailUrl":"https:\/\/innoprot.com\/wp-content\/uploads\/2025\/12\/Scientific-reports.jpg","datePublished":"2025-12-03T10:39:32+00:00","dateModified":"2026-01-19T12:29:53+00:00","description":"New preservative-free bilastine 0.6% effective in maintaining ocular surface integrity for allergic conjunctivitis treatment.","breadcrumb":{"@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#primaryimage","url":"https:\/\/innoprot.com\/wp-content\/uploads\/2025\/12\/Scientific-reports.jpg","contentUrl":"https:\/\/innoprot.com\/wp-content\/uploads\/2025\/12\/Scientific-reports.jpg","width":500,"height":500,"caption":"The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study"},{"@type":"BreadcrumbList","@id":"https:\/\/innoprot.com\/es\/article-published-the-new-preservative-free-ophthalmic-formulation-of-bilastine-0-6-preserves-the-ocular-surface-epithelial-integrity-in-a-comparative-in-vitro-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/innoprot.com\/es\/"},{"@type":"ListItem","position":2,"name":"Article Published: The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study"}]},{"@type":"WebSite","@id":"https:\/\/innoprot.com\/es\/#website","url":"https:\/\/innoprot.com\/es\/","name":"Innoprot","description":"Speeding up drug discovery","publisher":{"@id":"https:\/\/innoprot.com\/es\/#organization"},"alternateName":"Innoprot","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innoprot.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/innoprot.com\/es\/#organization","name":"Innoprot","alternateName":"Innoprot","url":"https:\/\/innoprot.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/innoprot.com\/es\/#\/schema\/logo\/image\/","url":"http:\/\/innoprot.com\/wp-content\/uploads\/2025\/03\/logo-blanco-innoprot-1.png","contentUrl":"http:\/\/innoprot.com\/wp-content\/uploads\/2025\/03\/logo-blanco-innoprot-1.png","width":201,"height":54,"caption":"Innoprot"},"image":{"@id":"https:\/\/innoprot.com\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/innoprot.com\/es\/#\/schema\/person\/62d601aa196bf9199550a161636ed83f","name":"Innoprot","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/caa3a92dcc44f0c616f60f902c05e27a6a7a2d94157c9a2329dc725e1d3a5966?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/caa3a92dcc44f0c616f60f902c05e27a6a7a2d94157c9a2329dc725e1d3a5966?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/caa3a92dcc44f0c616f60f902c05e27a6a7a2d94157c9a2329dc725e1d3a5966?s=96&d=mm&r=g","caption":"Innoprot"}}]}},"_links":{"self":[{"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/posts\/16433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/users\/9192194"}],"replies":[{"embeddable":true,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/comments?post=16433"}],"version-history":[{"count":1,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/posts\/16433\/revisions"}],"predecessor-version":[{"id":16436,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/posts\/16433\/revisions\/16436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/media\/16434"}],"wp:attachment":[{"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/media?parent=16433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/categories?post=16433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/innoprot.com\/es\/wp-json\/wp\/v2\/tags?post=16433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}